3350 pharmacology of spasms, spasticity, paralytics, and anesthetics

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/69

encourage image

There's no tags or description

Looks like no tags are added yet.

70 Terms

1
New cards

spasm

painful involuntary muscle contraction of muscle/muscle group in localized area that reduces muscle function caused by epilepsy, hypocalcemia, localized muscle injury

2
New cards

spasticity

group of movement disorders of CNS origin- heightened muscle tone, spasm, loss of dexterity caused by MS, cerebral palsy

3
New cards

drugs for spasms

cyclobenzaprine, diazepam

4
New cards

cyclobenzaprine mechanism of action

relaxes muscle through central suppression of tonic somatic motor activity

5
New cards

cyclobenzaprine adverse effects

generalized CNS depression, anticholinergic effects

6
New cards

cyclobenzaprine precautions

contraindicated with MAOIs and other antidepressants (2 weeks between agents due to risk of serotonin syndrome), CNS depressants

7
New cards

drugs for spasticity

baclofen, dantrolene, diazepam

8
New cards

baclofen mechanism of action

reduces hyperactive reflexes by blocking signal transduction through spinal cord, preserves skeletal muscle strength

9
New cards

baclofen adverse effects

generalized CNS depression, urinary retention, withdrawal (avoid abrupt cessation)

10
New cards

baclofen precautions

contraindicated with CNS depressants, BPH or anticholinergic drugs (urinary retention), schizophrenia or psychiatric illness

11
New cards

dantrolene mechanism of action

reduce skeletal muscle contraction directly by blocking calcium release from sarcoplasmic reticulum

12
New cards

dantrolene uses

malignant hyperthermia, neuroleptic malignant syndrome

13
New cards

dantrolene adverse effects

muscle weakness, hepatotoxicity

14
New cards

neuroleptic malignant syndrome

caused by dopamine receptor blockage, occurs with antipsychotics, usually occurs early in therapy

15
New cards

neuroleptic malignant syndrome s/s

fever, increased muscle tone, LOC, confusion, diaphoresis, dysrhythmias, rhabdomyolysis, respiratory failure, kidney injury

16
New cards

skeletal muscle contraction

signals sent from brain cause release of ACh that activates nicotinic muscle receptors at neuromuscular junction, causing depolarization of membrane and repolarization to keep action going

17
New cards

paralytics prevent skeletal muscle contraction by 2 mechanisms:

non-depolarizing neuromuscular blockade and depolarizing neuromuscular blockade

18
New cards

non-depolarizing neuromuscular blockade- cholinergic antagonists

pacuronium, rocuronium, vecuronium

19
New cards

cholinergic antagonists therapeutic uses

surgery, mechanical ventilation, endotracheal intubation

20
New cards

cholinergic antagonists mechanism of action

induce paralysis by blocking neuromuscular junction, preventing depolarization

21
New cards

cholinergic antagonists adverse effects

respiratory arrest

22
New cards

cholinergic antagonists interactions

cholinesterase inhibitors (-stigmine) reverse neuromuscular blockade

23
New cards

depolarizing neuromuscular blockade- agonist that prevents reset

succinylcholine

24
New cards

succinylcholine therapeutic uses

short action, endotracheal intubation

25
New cards

succinylcholine mechanism of action

induce paralysis by agonizing neuromuscular junction to the point where it can’t reset

26
New cards

succinylcholine adverse effects

respiratory arrest, malignant hyperthermia, postop muscle pain, hyperkalemia

27
New cards

succinylcholine contraindications

family Hx of malignant hyperthermia, severe traumatic injuries

28
New cards

succinylcholine interactions

cholinesterase inhibitors (-stigmine) intensify paralysis

29
New cards

sugammade X

safest option to reverse paralysis, used to bind up excess paralytic drugs, replacing use of cholinesterase inhibitors

30
New cards

local anesthetics

block signal transmission to muscle, block perception of sensation

loss of muscle function, anesthesia, analgesia

31
New cards

topical local anesthetic uses

pain, itching, soreness

32
New cards

injected local anesthetic uses

infiltration, nerve block, epidural anesthesia

33
New cards

local anesthetics

lidocaine, chloroprocaine

34
New cards

local anesthetics mechanism of action

suppress pain and other sensations by blocking sodium channels which block neuronal conduction, duration of action depends on blood flow, combine with vasoconstrictor (epinephrine) to reduce blood flow and prolong effects

35
New cards

local anesthetics adverse effects

bradycardia, heart block, reduced contractile force, cardiac arrest, hypotension, risk of seizure

36
New cards

local anesthetics OB adverse effects

delayed labor, neonatal bradycardia, CNS depression

37
New cards

ester type local anesthetic

chloroprocainem, topical benzocaine

more likely to have allergic reaction, risk of methemoglobinemia, avoid in kids <2 years, cocaine still approved for ENT procedures, adrenergic effects, CNS excitation, not formulated with epinephrine

38
New cards

amide type local anesthetics

lidocaine

most widely used anesthetic, used in epidurals for childbirth, IV fluids before administration to reduce hypotensive episode

39
New cards

inhaled general anesthetics

isoflurane, desflurane, sevoflurane, nitrous oxide

40
New cards

inhaled general anesthetic mechanism of action

depress excitation, enhance inhibition

41
New cards

inhaled general anesthetics potency

measured by minimum alveolar concentration/MAC (minimum concentration of drug in alveolar air that will produce immobility in 50% of pts)

42
New cards

-fluranes MAC

desirable MAC values for anesthesia

isoflurane=1.15%

desflurane=4.58%

sevoflurane 1.71%

43
New cards

inhaled general anesthetics adverse effects

respiratory and cardiac depression, sensitization of heart to catecholamines (DA, NE, epinephrine, dobutamine, isoproterenol), increased risk for aspiration, malignant hyperthermia (-fluranes), N&V (nitrous oxide)

44
New cards

nitrous oxide

drug of abuse (whippets), can cause slurred speech, loss of coordination, euphoria, dizziness, effects last a few minutes

45
New cards

inhaled general anesthetics interactions

CNS stimulants and cocaine- decrease anesthetic effects

CNS depressants and opioids- increase anesthetic effects

46
New cards

inhaled pre-anesthetics

benzodiazepines, opioids, alpha 2 agonists (dexmedetomidine)

47
New cards

inhaled anesthetics during surgery

anticholinergics (atropine), neuromuscular blocking agents

48
New cards

inhaled post-anesthetics

analgesics, antiemetics, muscarinic agonists

49
New cards

IV general anesthetics

propofol, ketamine, short-acting barbiturates (methohexital), benzodiazepines

50
New cards

propofol

most widely used IV anesthetic, magic milk/milk of anesthesia, rapid acting, unconscious in 60secs, lasts 3-5mins, no N&V, no analgesia

51
New cards

propofol risks

respiratory depression, hypotension, bacterial infection (highly lipophilic=good for bacterial growth, discard vial after opened for 6hrs), pain at injection site, risk of abuse (refreshed/euphoric effect)

52
New cards

ketamine

dissociative anesthesia- sedation, immobility, analgesia, amnesia, safer for pts with bronchospasms

53
New cards

ketamine adverse effects

hallucinations, disturbing dreams, delirium (avoid in pts with psychiatric illness), potential for abuse

54
New cards

dissociative drugs of abuse

ketamine, phencyclidine, dextromethorphan

55
New cards

phencyclidine and dextromethorphan

high doses cause euphoria, lack of inhibitions, mood swings, dissociation, anxiety, reduced perception of tactile and painful stimuli, HTN, tachycardia, hallucinations, confusion, psychosis, combativeness

56
New cards

phencyclidine and dextromethorphan mechanism of action

antagonize NMDA receptors to produce dissociation from reality

57
New cards

CNS depressants

alcohol, GHB, barbiturates, benzodiazepines

58
New cards

alcohol

most used and abused psychoactive agent in the US

59
New cards

alcohol mechanism of action

agonizes GABA receptors and blocks glutamate receptors, activation of reward through agonizing 5-HT receptors and stimulating DA release

60
New cards

acute effects of alcohol

depression of brain function, blunting thought processes and behaviors, release of inhibitions and self-restraint, increased sociability, impaired motor function, N&V, LOC, respiratory depression, coma

61
New cards

chronic effects of alcohol

neurological and psychiatric disorders (Wernicke encephalopathy and Korsakoff psychosis), injury to CNS from alcohol and nutritional deficiencies, atrophy of brain, cancer

62
New cards

CV effects of alcohol

damage to myocardium, dilation of cutaneous blood vessels causes warm sensation, HTN

63
New cards

systemic effects of alcohol

suppressed gluconeogenesis→hypoglycemia, depressed respiration, nonviral hepatitis, cirrhosis, erosive gastritis, stomach and pancreas damage, diuresis, reduced sexual responsiveness

64
New cards

alcohol pharmacokinetics

80% absorbed in small intestine, rapid but dependent on gastric emptying, 20% absorbed in stomach, absorption delayed by food, distributed to all tissues, crosses BBB and placenta, metabolized in liver, zero order elimination

65
New cards

alcohol interactions through metabolism

acetaminophen, disulfiram

66
New cards

alcohol interactions through adverse effects

CNS depressants, NSAIDs, antihypertensives

67
New cards

managing alcohol OD

high risk of aspiration, unresponsive to vasoconstrictors→renal failure and CV shock

68
New cards

alcohol use disorder

cross tolerance occurs with other CNS depressants but not opioids for tolerance, physical dependence, and abstinence syndrome

69
New cards

alcohol withdrawal symptoms

anxiety, depression, fatigue, irritability, sweating, clammy skin, fever, hallucinations, seizure, possible death

70
New cards

alcohol withdrawal treatment

benzodiazepines, beta blockers, clonidine, carbamazepine